Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $824.02 | 24 | 50.5% |
| Travel and Lodging | $807.11 | 4 | 49.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $1,421 | 21 | $0 (2017) |
| AbbVie, Inc. | $112.24 | 2 | $0 (2017) |
| GENZYME CORPORATION | $36.93 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $18.45 | 1 | $0 (2020) |
| Monaghan Medical Corporation | $17.51 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $13.89 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $11.40 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36.93 | 1 | GENZYME CORPORATION ($36.93) |
| 2022 | $13.89 | 1 | AstraZeneca Pharmaceuticals LP ($13.89) |
| 2020 | $18.45 | 1 | Paratek Pharmaceuticals, Inc. ($18.45) |
| 2018 | $17.51 | 1 | Monaghan Medical Corporation ($17.51) |
| 2017 | $1,544 | 24 | Shionogi Inc ($1,421) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: Immunology | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Respiratory | ||||||
| 11/17/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ANTIBIOTIC | ||||||
| 03/07/2018 | Monaghan Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Aero Chamber | ||||||
| 11/28/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $90.72 | General |
| Category: Immunology | ||||||
| 11/13/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 10/27/2017 | Shionogi Inc | — | Travel and Lodging | Cash or cash equivalent | $155.57 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $58.99 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $49.61 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 10/27/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 10/26/2017 | Shionogi Inc | — | Travel and Lodging | Cash or cash equivalent | $213.57 | General |
| 10/26/2017 | Shionogi Inc | — | Travel and Lodging | Cash or cash equivalent | $165.57 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $133.11 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $58.99 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $49.61 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 10/26/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 10/25/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $52.46 | General |
| 10/25/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $18.16 | General |
| 10/25/2017 | Shionogi Inc | — | Food and Beverage | In-kind items and services | $16.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 103 | 196 | $80,365 | $24,263 |
| 2022 | 4 | 193 | 307 | $136,461 | $39,835 |
| 2021 | 4 | 257 | 505 | $230,210 | $69,037 |
| 2020 | 4 | 232 | 423 | $175,011 | $55,794 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 99 | $60,687 | $16,476 | 27.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 64 | $14,464 | $5,782 | 40.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 33 | $5,214 | $2,006 | 38.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 86 | 168 | $103,082 | $28,849 | 28.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 65 | $14,963 | $5,136 | 34.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $10,228 | $3,137 | 30.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 51 | $8,188 | $2,714 | 33.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 117 | 292 | $179,288 | $51,609 | 28.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 73 | 120 | $27,960 | $9,570 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 27 | $12,204 | $4,147 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 66 | $10,758 | $3,711 | 34.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 86 | 196 | $120,344 | $36,377 | 30.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 63 | 112 | $26,096 | $9,284 | 35.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 32 | 34 | $15,368 | $5,342 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 51 | 81 | $13,203 | $4,791 | 36.3% |
About Dr. Hollis Oneal, MD
Dr. Hollis Oneal, MD is a Pulmonary Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497896823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hollis Oneal, MD has received a total of $1,631 in payments from pharmaceutical and medical device companies, with $36.93 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($824.02).
As a Medicare-enrolled provider, Oneal has provided services to 785 Medicare beneficiaries, totaling 1,431 services with total Medicare billing of $188,929. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Baton Rouge, LA
- Active Since 02/09/2007
- Last Updated 07/25/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1497896823
Products in Payments
- Humira (Biological) $112.24
- DUPIXENT (Biological) $36.93
- NUZYRA (Drug) $18.45
- TEZSPIRE (Biological) $13.89
- ANORO (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baton Rouge
Robert Hinkle, Md, MD
Pulmonary Disease — Payments: $32,737
Dr. Alexander Mulamula, M.d, M.D
Pulmonary Disease — Payments: $9,086
Vincent Valentine, Md, MD
Pulmonary Disease — Payments: $6,427
Mostafa Aboubakr, Md, MD
Pulmonary Disease — Payments: $4,838
Stephen Brierre, Md, MD
Pulmonary Disease — Payments: $2,385
Jonathan Richards, Md, MD
Pulmonary Disease — Payments: $2,365